Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1124972

registered interest
date	07/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Phenylketonuria
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he has plans to extend free prescriptions to people with phenylketonuria; and if he will make a statement.
tabling member constituency	Birmingham, Edgbaston
tabling member printed	Preet Kaur Gill
uin	251355
answer	answer is ministerial correction date of answer 15/05/2019 answer text <p>The Department has no current plans to extend free prescriptions or to assess the merits of adding phenylketonuria (PKU) to the list of medical conditions that provide exemption from prescription charges. Extensive arrangements are already in place to help people afford National Health Service prescriptions. These include a broad range of NHS prescription charge exemptions, for which someone with PKU may qualify.</p><p>To support those with greatest need who do not qualify for an exemption, prescription prepayment certificates are available. A holder of a 12-month certificate can get all the prescriptions they need for just £2 per week.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 251356 question first answered 15/05/2019 16:09:08 answering member 4455 label Biography information for Seema Kennedy
tabling member	4603 label Biography information for Preet Kaur Gill

1124973

registered interest
date	07/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescriptions: Fees and Charges
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of adding phenylketonuria to the list of medical exemptions for prescription charges.
tabling member constituency	Birmingham, Edgbaston
tabling member printed	Preet Kaur Gill
uin	251356
answer	answer is ministerial correction date of answer 15/05/2019 answer text <p>The Department has no current plans to extend free prescriptions or to assess the merits of adding phenylketonuria (PKU) to the list of medical conditions that provide exemption from prescription charges. Extensive arrangements are already in place to help people afford National Health Service prescriptions. These include a broad range of NHS prescription charge exemptions, for which someone with PKU may qualify.</p><p>To support those with greatest need who do not qualify for an exemption, prescription prepayment certificates are available. A holder of a 12-month certificate can get all the prescriptions they need for just £2 per week.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 251355 question first answered 15/05/2019 16:09:08 answering member 4455 label Biography information for Seema Kennedy
tabling member	4603 label Biography information for Preet Kaur Gill

1124974

registered interest
date	07/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Phenylketonuria: Sapropterin
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether the NICE appraisal of Kuvan will consider the increased prevalence of neuropsychiatric comorbidities in adults with phenylketonuria.
tabling member constituency	Birmingham, Edgbaston
tabling member printed	Preet Kaur Gill
uin	251357
answer	answer is ministerial correction date of answer 15/05/2019 answer text <p>In developing its recommendations on Kuvan, the National Institute for Health and Care Excellence (NICE) will consider all the health-related costs and benefits associated with the treatment in accordance with its published methods and processes and the scope for the appraisal that has been developed in consultation with stakeholders; potentially including any costs from National Health Service funded treatments that can be avoided such as food supplements. The NICE appraisal of Kuvan is now underway and NICE expects to publish final guidance next year.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 251358 question first answered 15/05/2019 16:31:51 answering member 4455 label Biography information for Seema Kennedy
tabling member	4603 label Biography information for Preet Kaur Gill

1124975

registered interest
date	07/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Sapropterin
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 November 2018 to Question 190518 on Sapropterin, whether the NICE appraisal of Kuvan will take into account the costs from NHS funded treatments that can be avoided such as food supplements.
tabling member constituency	Birmingham, Edgbaston
tabling member printed	Preet Kaur Gill
uin	251358
answer	answer is ministerial correction date of answer 15/05/2019 answer text <p>In developing its recommendations on Kuvan, the National Institute for Health and Care Excellence (NICE) will consider all the health-related costs and benefits associated with the treatment in accordance with its published methods and processes and the scope for the appraisal that has been developed in consultation with stakeholders; potentially including any costs from National Health Service funded treatments that can be avoided such as food supplements. The NICE appraisal of Kuvan is now underway and NICE expects to publish final guidance next year.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 251357 question first answered 15/05/2019 16:31:51 answering member 4455 label Biography information for Seema Kennedy
tabling member	4603 label Biography information for Preet Kaur Gill